Performance of Candidate Serum Biomarkers for Systemic Sclerosis –Associated Interstitial Lung Disease

ConclusionThese results show that SP ‐D is a relevant diagnostic biomarker for SSc‐associated ILD, whereas KL‐6 could be used to assess the severity of lung fibrosis. CCL18 appears to be a potential predictive marker for progression of ILD in SSc.

Source: Arthritis and Rheumatology - April 25, 2019 Category: Rheumatology Authors: Muriel Elhai, Anna Maria Hoffmann ‐Vold, Jérôme Avouac, Sonia Pezet, Anne Cauvet, Agathe Leblond, Håvard Fretheim, Torhild Garen, Masataka Kuwana, Øyvind Molberg, Yannick Allanore Tags: Original Article Source Type: research